7 Hills Pharma to Deliver Video Presentation At BIO Digital 2020 June 8 – 12
04 juin 2020 12h58 HE
|
7 Hills Pharma
Company is leveraging its integrin platform technology to improve effectiveness of immunotherapies, including Covid-19 vaccines HOUSTON, June 04, 2020 (GLOBE NEWSWIRE) -- 7 Hills Pharma, a...
Amid COVID-19 Vaccine Race, Sabin Vaccine Institute and the Aspen Institute Release Report on Vaccine Hesitancy; A Call to Improve Vaccine Acceptance
02 juin 2020 10h00 HE
|
The Sabin Vaccine Institute
Washington, D.C., June 02, 2020 (GLOBE NEWSWIRE) -- As the COVID-19 vaccine race accelerates, experts recognize that the challenge will not end with the development of a vaccine. The extraordinary...
Translate Bio to Present at Jefferies Virtual Healthcare Conference
28 mai 2020 07h30 HE
|
Translate Bio, Inc.
LEXINGTON, Mass., May 28, 2020 (GLOBE NEWSWIRE) -- Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative...
Innovation Pharmaceuticals Receives Data from Public Health Research Institute Showing Brilacidin Inhibits SARS-CoV-2 (COVID-19) in a Human Cell Line
26 mai 2020 08h00 HE
|
Innovation Pharmaceuticals Inc.
Brilacidin showed a dose-dependent inhibitory response in a human kidney cell line expressing hACE2Data supports Brilacidin’s potential to prevent SARS-CoV-2 binding to the hACE2 receptor, the method...
Innovation Pharmaceuticals’ Brilacidin Reduces Viral Titer of SARS-CoV-2 (COVID-19) by 75 percent After Only 1 Hour of Preincubation in In Vitro Study at BSL-3 Facility; Demonstrates Potent and Rapid Virucidal Activity
19 mai 2020 07h30 HE
|
Innovation Pharmaceuticals Inc.
Experiment supports Brilacidin’s therapeutic potential as a COVID-19 treatment and as a prophylactic agent against COVID-19 WAKEFIELD, Mass., May 19, 2020 (GLOBE NEWSWIRE) -- Innovation...
Inhibitory Effect of Innovation Pharmaceuticals’ Brilacidin on SARS-CoV-2 (COVID-19) in Primary Human Immune Cells to be Studied at Leading Public Health Research Institute
05 mai 2020 09h30 HE
|
Innovation Pharmaceuticals Inc.
WAKEFIELD, Mass., May 05, 2020 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to report the Company has executed...
Pfizer und BioNTech impfen erste US-Studienteilnehmer im Rahmen des globalen Programms zur COVID-19-mRNA-Impfstoffentwicklung
05 mai 2020 06h45 HE
|
BioNTech SE
Erste Teilnehmer an der NYU Grossman School of Medicine und der University of Maryland School of Medicine behandeltPfizer und BioNTech erhöhen Produktionsleistung, um Kapazitäten in den Jahren...
Pfizer and BioNTech Dose First Participants in the U.S. as Part of Global COVID-19 mRNA Vaccine Development Program
05 mai 2020 06h45 HE
|
BioNTech SE
First participants dosed at NYU Grossman School of Medicine and University of Maryland School of MedicinePfizer and BioNTech ramping up manufacturing capabilities to further increase production...
MMR Vaccine Likely Why COVID-19 Rarely Hitting Young According to World Organization
03 mai 2020 07h02 HE
|
World Organization
ATLANTA, May 03, 2020 (GLOBE NEWSWIRE) -- The report MMR Vaccine Link to COVID-19: Fewer Deaths and Milder Cases from SARS-CoV-2 in Measles-Rubella Vaccinated Populations reveals that the MMR...
MMR Vaccine May Protect People Over 50 from COVID-19 According to World Organization
29 avr. 2020 09h01 HE
|
World Organization
ATLANTA, April 29, 2020 (GLOBE NEWSWIRE) -- Epidemiological data revealed in an MMR vaccines and COVID-19 investigation by World Organization suggests it is possible that widely deployed MMR and...